Neuronetics (STIM) Net Cash Flow Growth (3y) (2020 - 2026)
Neuronetics (STIM) Net Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -48.90% |
| 10 | Neuronetics | 120.74 Mn | 114.73 Mn | 16.15 Mn | -0.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.61% |
| Dec 31, 2025 | 53.16% |
| Sep 30, 2025 | 83.11% |
| Jun 30, 2025 | 27.61% |
| Mar 31, 2025 | 28.72% |
| Dec 31, 2024 | 35.76% |
| Sep 30, 2024 | 30.86% |
| Jun 30, 2024 | 2.53% |
| Mar 31, 2024 | -29.37% |
| Dec 31, 2023 | 149.46% |
| Sep 30, 2023 | -45.33% |
| Jun 30, 2023 | 0.39% |
| Mar 31, 2023 | -7.29% |
| Dec 31, 2022 | 20.42% |
| Sep 30, 2022 | 33.52% |
| Jun 30, 2022 | -15.07% |
| Mar 31, 2022 | -16.39% |
| Dec 31, 2021 | -34.61% |
| Sep 30, 2021 | -29.61% |
| Jun 30, 2021 | 1.85% |